Interferon alfa-2b biosimilar (Shantha Biotechnics)

干扰素α-2b生物类似药 (Shantha Biotechnics)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon alfa-2b biosimilar (Shantha Biotechnics)

Drug Alias NamePEGylated interferon alfa-2b (TheraPEG)

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionImmunostimulantsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists

TargetsInterferon alpha/beta receptor

Therapy Area/IndicationsHepatitis C

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSanofi

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSanofi

Active IndicationsN/A

Inactive IndicationsHepatitis C

ATC CodeL03AB05